tiprankstipranks
Trending News
More News >
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Cash flow

Compare
3 Followers

VitaSpring Biomedical Cash Flow

VSBC's free cash flow for Q3 2023 was $2.46K. For the 2023 fiscal year, VSBC's free cash flow was decreased by $-89.37K and operating cash flow was $2.46K. See a summary of the company’s cash flow.
Cash Flow
Jan 23Jan 22Jan 21Jan 20Jan 19
Operating Cash Flow
$ -77.56K$ 84.81K$ -42.13K$ -105.00$ -34.25K
Investing Cash Flow
$ 0.00$ -73.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 0.00$ 50.00K$ 87.53K$ 0.00$ 29.15K
End Cash Position
$ 29.66K$ 107.21K$ 45.40K$ 0.00$ 105.00
Free Cash Flow
$ -77.56K$ 11.81K$ -42.13K$ -105.00$ -34.25K
Currency in USD

VitaSpring Biomedical Cash Flow